Skip to content

Comparison of Remimazolam and Propofol for General Anesthesia Induction and Maintenance in Obese Patients undergoing laparoscopic sleeve gastrectomy

study of Remimazolam for General Anesthesia Induction and Maintenance in Obese Patients undergoing laparoscopic sleeve gastrectomy

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077040
Enrollment
Unknown
Registered
2023-10-27
Start date
2023-10-31
Completion date
Unknown
Last updated
2023-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients undergoing bariatric surgery

Interventions

Group E:Received general anesthesia and regional nerve block anesthesia, while group E was induced and maintained using Remimazolam. Maintain total intravenous anesthesia with Remimazolam 1-3mg/kg/h
Group C:Received general anesthesia and regional nerve block anesthesia, and group C was induced and maintained with propofol. Maintain total intravenous anesthesia with propofol 4-12mg/kg/h and remif

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1.1) diagnosed with obesity(BMI=30) , plan to undergo laparoscopic sleeve gastrectomy; (1.2)18=Age=60,Gender unlimited; (1.3)ASA ?~?; (1.4)Clearly understand, voluntarily participate in the study, and have their informed consent form signed by themselves

Exclusion criteria

Exclusion criteria: (2.1) Concomitant severe cardiovascular, pulmonary, and cerebral diseases, such as uncontrolled hypertension, coronary heart disease, congenital heart disease, valve disease, intracranial vascular malformations, asthma , COPD , etc; (2.2) Have a history of drug abuse; (2.3) Communication disorders, inability to cooperate with researchers, such as language comprehension disorders, mental illness, etc.; (2.4) A history of allergy to benzodiazepines; (2.5) Contraindications to pulmonary recruitment maneuvers (such as bullous lung disease), hemodynamic instability; (2.6) Patients who have used drugs that have a significant effect on the central nervous system in the past 3 months, or who have hearing loss or epilepsy. (2.7) Pregnant women; (2.8) Participants in other clinical trials within 3 months prior to study enrollment; (2.9) Other conditions deemed unsuitable for inclusion by the researcher.

Design outcomes

Secondary

MeasureTime frame
Postoperative nausea and vomiting;Postoperative Pain;Postoperative recovery of gastrointestinal function;Postoperative recovery time;Recovery time required for tracheal extubation;Postoperative oxygenation index;

Primary

MeasureTime frame
depth of anesthesia;Time weighted average of hypotension;

Countries

China

Contacts

Public ContactWei Ke

Anesthesiology Department of the First Affiliated Hospital of Chongqing Medical University

wk202448@hospital-cqmu.com+86 159 0236 0621

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026